col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Maad Rayan Publishing Company: Pharmaceutical Sciences
  original article Date Title Authors   All Authors
1 [GO] 2021―Nov―09 Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review Kavous Shahsavarinia, Morteza Ghojazadeh, Sarvin Sanaie, Leila Vahedi, Mahta Ahmadpour, Ata Mahmoodpoor, Hassan Soleimanpour
2 [GO] 2021―Sep―30 Natural products as inhibitors of COVID-19 main protease-A virtual screening by molecular docking Marzieh Omrani, Mohammad Bayati, Parvaneh Mehrbod, Kamal Asmari Bardazard, Samad Nejad-Ebrahimi
3 [GO] 2021―Sep―30 Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Mohammed Dahab, Ahmed Metwaly, Ibrahim Eissa
4 [GO] 2021―Sep―30 Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 patients Saeid Safari, Alireza Jahangirifard, Alireza Zali, Alireza Salimi, Ehsan Bastanhagh, Reza Aminnejad, et al. (+2)
5 [GO] 2021―Sep―30 The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis Leila Nikniaz, Mohammad Amin Akbarzadeh, Hossein Hosseinifard, Mohammad-Salar Hosseini
6 [GO] 2021―Sep―30 Acyclovir as a Potential Adjuvant Therapy in COVID-19 Treatment Regimens Fatemeh Heidary, Sedigheh Madani, Reza Gharebaghi, Fahimeh Asadi-amoli
7 [GO] 2021―Sep―30 Potential Roles of Vitamins in the Management of COVID-19: A Comprehensive Review Homa Rezaei, Sajad Khiali, Haleh Rezaee, Hossein Bannazadeh Baghi, Matin Pourghasem, Taher Entezari-Maleki
8 [GO] 2021―Sep―30 The clinical characteristics and treatment approaches of COVID-19: a concise review Sajjad Eslamkhah, Nazila Alizadeh, Khalil Hajiasgharzadeh, Masoud Eslamkhah, Ahad Mokhtarzadeh, Behzad Baradaran
9 [GO] 2021―Sep―30 A new possible indication of direct-acting anti-hepatitis C drugs in the therapeutic management of COVID-19: A narrative literature review Alireza Mashhadi Hemmatabadi, Fatemeh Jafari, Hesamoddin Hosseinjani
10 [GO] 2021―Sep―30 Anti-rheumatic drugs as potential anti-inflammatory, immunomodulatory agents against COVID-19: A systematic review Reza Sinaei, Sara Pezeshki, Ali Asadipour, Reza Shiari, Roya Sinaei, Ali Sinaei
11 [GO] 2021―Sep―30 The Integration of Pharmacophore-Based 3D QSAR Modeling and Virtual Screening in Identification of Natural Product Inhibitors against SARS-CoV-2 Samira Norouzi, Maryam Farahani, Samad Nejad Ebrahimi
12 [GO] 2021―Sep―30 Qualitative and quantitative analysis of anti-viral compounds against SARS-CoV-2 protease enzyme by molecular dynamics simulation and MM/PBSA method Saghi Sepehri, Niloufar Hashemidanesh, Karim Mahnam, Hila Asham
13 [GO] 2020―Dec―20 Dexmedetomidine: An All Sedation-in-One Drug in Critically Ill Patients with COVID-19 Ata Mahmoodpoor, Elyad Ekrami, Hassan Soleimanpour
14 [GO] 2020―Dec―20 Plasmapheresis: A New Strategy in the Treatment of COVID-19 Punet Kumar, Md Iftekhar Ahmad, Sangam Singh
15 [GO] 2020―Dec―20 A Rapid Strategy for Repurposing Drugs for COVID-19 Maryam Khoubnasabjafari, Masoud Amanlou, Ahmadreza Dehpour, Abolghasem Jouyban
16 [GO] 2020―Dec―20 Higher Education System in Light of Covid-19 Jalal Hanaee, Mohammad Reza Rashidi
17 [GO] 2020―Dec―20 Diabetes and the COVID-19 Pandemic: What Should the Diabetes Patients Know? Moyad Shahwan, Nageeb Hassan, Sahab Alkhoujah, Ammar Jairoun, Samer Zyoud, Sudhir Varma
18 [GO] 2020―Dec―20 COVID-19: A Devastating Pandemic Punet Kumar, Md Iftekhar Ahmad, Sangam Singh
19 [GO] 2020―Dec―20 NSAIDs and COVID-19: A New Challenging Area Hananeh Baradaran, Hadi Hamishehkar, Haleh Rezae
20 [GO] 2020―Dec―20 COVID-19: Clinical Characteristics and Molecular Levels of Candidate Compounds of Prospective Herbal and Modern Drugs in Indonesia Robert Tungadi, Teti Sutriyati Tuloli, Widysusanti Abdulkadir, Nurain Thomas, Madania Madania, Ani Mustapa Hasan, Zulfiayu Sapiun
21 [GO] 2020―Dec―20 A Summary of Coronavirus Disease 2019: What We Should Know? Ysrafil Ysrafil, Indwiani Astuti, Rosdiana Mus, Noviyanty Indjar Gama, Dwi Rahmaisyah, Riskah Nur’amalia
22 [GO] 2020―Dec―20 Prophylactic Use of Chloroquine May Impair Innate Immune System Response against SARS-Cov-2 Hamid Soraya
23 [GO] 2020―Dec―20 In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2 Baby Krishnaprasad, Swastika Maity, Chetan Mehta, Akhil Suresh, Usha Y Nayak, Yogendra Nayak
24 [GO] 2020―Dec―20 Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors Mohammad Rizki Fadhil Pratama, Hadi Poerwono, Siswandono Siswodihardjo
25 [GO] 2020―Dec―20 Persistence of SARS-Cov-2 on the Beauty Products, Their Containers’ Surfaces, and the Possibility of Secondary and Cross-Contamination Zahra Jannatdoust, Sara Shamekhi, Jalal Hanaee, Somaieh Soltani, Alireza Garjani
26 [GO] 2020―Dec―20 Investigational Drugs for the COVID 19 Pandemic - A Concise Review Reena Sherin Parveen, Sherya Hegde, Veena Nayak


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.009 sec